November 27, 2021

Telaleaf Health Inc. Announces Partnership with Franjo Grotenhermen, M.D. to Deliver Expert-Led Virtual Medical Cannabis CareAcross Germany

Berlin, Germany, November 27, 2021 — TelaleafHealth Inc. (“Telaleaf” or the “Company”), a telemedicine company transformingthe access and delivery of medical cannabis care to patients, is pleased toannounce a strategic partnership with internationally respected expert onpharmacological and medical cannabis and cannabinoids Franjo Grotenhermen, M.D.(“Dr. Grotenhermen”) to empower patients by delivering expert medical cannabiscare across Germany through Telaleaf’s virtual platform.

 

Under the partnership, patients will be able to book virtualmedical visits with Dr. Grotenhermen and his expert team via Telaleaf –providing patients with convenient and secure access to the world’s top medicalcannabis physicians and researchers, from the comfort of their home. Thepartnership provides a first-of-its-kind expert-led service for receivingcannabis-based treatment from the world’s top specialists in ­the field, andfits seamlessly into one integrated, comprehensive virtual care solution.

 

The partnership will also focus on establishing content, resourcesand learning for all levels of cannabis medicine education and training todoctors in order to develop and fortify the field with leading authorities suchas Dr. Grotenhermen at its helm.

 

"Partnering with such an accomplished expert is a tremendousopportunity for us to help more patients receive accurate, personalized andin-depth cannabis-based treatment plans. Our mutual focus is on empoweringpatients by providing easy access to the best cannabis care the world has tooffer, as well as training more doctors to deliver the highest standard ofcare. This is the first step in transforming and advancing the future ofcannabis-based medicine in Germany and beyond,” said Telaleaf co-founder, EvaAllouche.

 

Dr. Grotenhermen has been a leading medical cannabis researcherfor over two decades. As a practicing physician, Dr. Grotenhermen bringsunparalleled clinical expertise and experience to Telaleaf. He has treatedinnumerable patients and is an internationally respected expert on thetherapeutic use of cannabinoids and cannabis-based treatment plans. He hasauthored more than 50 peer-reviewed journal articles, has written or edited 11cannabis science books, and serves on various scientific review committees. Heis the founder and executive director of the highly regarded, clinicallyfocused International Association for Cannabinoid Medicines and is thepresident of the German Association for Medical Cannabis. His leadership in thespace has garnered him high regard among his peers as a leading authority oncannabinoid pharmacology across the world.

 

Telaleaf CEO Gavin Treanor said, “We have long admired Dr.Grotenhermen’s work that prioritizes patient needs in medical cannabis, and weare honoured to be partnering with one of the world’s most respected andsought-after figures in the field to provide a premium-level service topatients. We established Telaleaf, and this partnership in particular, becausepatients should never have to grapple with the challenges of getting accuratecannabis-based treatment plans and critical answers for complex physical,neurological and mental conditions. This partnership provides access to anexpert service unlike any other in medical cannabis.”

 

About Telaleaf

Telaleaf is a telemedicine company revolutionizing the delivery ofcannabis care by connecting patients to expert doctors, trained incannabis-based medicine, who conduct virtual medical visits. Our aim is toimprove patient outcomes by improving the patient experience with cutting-edgetechnology, simplicity, low costs and expert-led education, for the mostadvanced virtual care in cannabis medicine.

 

About Franjo Grotenhermen, M.D.

Dr. Franjo Grotenhermen, is a world-renown leader and expert onthe therapeutic use of cannabinoids. He is the chairman of the CannabisAssociation(ACM), and founder and Managing Director of the InternationalAssociation for Cannabinoid Medicines (IACM) for over 20 years. His bookCannabis Healing is recognized as the most authoritative guide on thetherapeutic application of medical cannabis. His expertise is highly respectedand sought-after amongst governmental bodies, pharmaceutical companies andinternational institutions such as the World Health Organization and theAmerican Herbal Pharmacopoeia.